Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Dynamk Capital Announces Advisor Dream Team | ||
By: PR Newswire Association LLC. - 19 Jun 2018 | Back to overview list |
|
ENGLEWOOD CLIFFS, N.J., June 19, 2018 /PRNewswire/ -- Dynamk Capital, a venture fund providing early stage and growth capital to innovative Life Science tools and service providers, announces their all-star list of advisors. Dynamk has paved the way for startups with disruptive technologies and services to gain vital capital to reach the next phase. Dynamk's partners have leveraged its network of fellow entrepreneurs, industry thought leaders and disrupters in creating a team of advisors to help ensure sound strategic decisions aimed at maximizing returns for investors. When assembling the team, Dynamk sought domain experts with deep technical knowledge, a proven track record of successful businesses, and most of all, a keen sense of where the industry is trending. The advisor list is a who's who of widely respected experts in their field:
Barry Buckland commented, "Dynamk Capital has an important role to fill in the Biopharmaceutical industry by making strategic investments to accelerate commercialization of innovative tools and technologies." General Partner Daniella Kranjac commented, "The team of advisors will bring insights on best practices and operational excellence needed for early stage companies. They are also well aware of all the key players likely for exiting to and how innovative technologies can fill gaps in their portfolios. This will ensure that companies which are highly likely to succeed are brought into the fund and will be best positioned to exit with maximum returns." Kevin Bailey commented, "Dynamk Capital has the rare opportunity to help accelerate research, development and manufacturing in the biopharma industry by identifying companies with disruptive new technologies and facilitating getting them into the hands of those who will bring new products and hope to patients." About Dynamk Capital Contacts Media and Investors: View original content with multimedia:http://www.prnewswire.com/news-releases/dynamk-capital-announces-advisor-dream-team-300668133.html SOURCE Dynamk Capital |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |